Enhua Wang
Cardiovascular Disease · Philadelphia, PANPI 1790399798
Payments from drug & device makers
Across 76 payments — averaging $49.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abiomed$678
- Boston Scientific$633
- Abbott$553
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$370
- W. L. Gore & Associates, Inc.$238
- Biosense Webster, Inc.$190
- plus $1K from 18 others
What the payments were for
- Grants$40011%
- Food & beverage$2,96578%
- Education$43211%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abiomed | 10 | $678 |
| Boston Scientific | 4 | $633 |
| Abbott | 9 | $553 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 10 | $370 |
| W. L. Gore & Associates, Inc. | 2 | $238 |
| Biosense Webster, Inc. | 3 | $190 |
| Pfizer | 10 | $174 |
| Penumbra, Inc. | 1 | $143 |
| Teleflex LLC | 2 | $115 |
| Johnson & Johnson | 1 | $105 |
| Actelion Pharmaceuticals US, Inc. | 1 | $97 |
| Vanda Pharmaceuticals Inc. | 3 | $81 |
| Irhythm Technologies, Inc. | 2 | $81 |
| Boehringer Ingelheim | 3 | $57 |
| Alnylam Pharmaceuticals Inc. | 2 | $45 |
| Heartflow, Inc. | 2 | $42 |
| AstraZeneca | 3 | $42 |
| Philips North America LLC | 1 | $36 |
| Merck | 2 | $34 |
| Bayer | 1 | $27 |
| Impulse Dynamics (USA) Inc. | 1 | $17 |
| Nestle Healthcare Nutrition Inc. | 1 | $15 |
| Mylan Specialty L.p. | 1 | $15 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL CATHETER$400
- ENSITE$382
- Impella$265
- GORE VIABAHN VBX Balloon Expandable Endo$188
- GENERAL VASCULAR ACCESS$171
- Indigo System$143
- LifeVest$117
- XARELTO$105
- Carto 3$101
How this compares
$3,796 in reported general payments places this provider in the 65th percentile of 1,250 cardiovascular disease providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nifedipine ErNifedipine | 21 | $524 |
| Rosuvastatin Calcium | 14 | $506 |
| Bumetanide | 11 | $318 |
| Ezetimibe | 12 | $307 |
| Atorvastatin Calcium | 39 | $300 |
| Metoprolol Succinate | 16 | $228 |
| Carvedilol | 20 | $222 |
| Hydrochlorothiazide | 20 | $73 |
| Losartan Potassium | 12 | $68 |
| Amlodipine Besylate | 14 | $55 |
| Furosemide | 11 | $35 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Philadelphia
- Danielle DuffyPhiladelphia$29.5M
- Brian DrachmanPhiladelphia$3.8M
- Bonnie KyPhiladelphia$1.9M
- Marielle Scherrer CrosbiePhiladelphia$1.6M
- Paul ForfiaPhiladelphia$1.2M
- Quang BuiPhiladelphia$933K
- Leandro Slipczuk BustamantePhiladelphia$638K
- William MatthaiPhiladelphia$542K
- Dean KaralisPhiladelphia$463K
- Nehal MehtaPhiladelphia$419K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.